These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28864411)

  • 1. "Revisions of the International Consensus Fukuoka Guidelines for the Management of IPMN of the Pancreas": Progress for twelve years.
    Takaori K
    Pancreatology; 2017; 17(5):645-646. PubMed ID: 28864411
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients.
    Goh BK; Lin Z; Tan DM; Thng CH; Khor CJ; Lim TK; Ooi LL; Chung AY
    Surgery; 2015 Nov; 158(5):1192-202. PubMed ID: 26032832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.
    Aronsson L; Andersson R; Ansari D
    Scand J Gastroenterol; 2017 Aug; 52(8):803-815. PubMed ID: 28446039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraductal papillary-mucinous neoplasm of the pancreas].
    Yamaguchi K; Watanabe M; Nakamura M; Konomi H; Tanaka M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():52-9. PubMed ID: 16457221
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?
    Bassi C; Crippa S; Salvia R
    Gut; 2008 Mar; 57(3):287-9. PubMed ID: 18268051
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.
    Fonseca AL; Kirkwood K; Kim MP; Maitra A; Koay EJ
    Pancreas; 2018 Mar; 47(3):272-279. PubMed ID: 29424809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical management of intraductal papillary mucinous neoplasm].
    Kim YT
    Korean J Gastroenterol; 2008 Oct; 52(4):214-9. PubMed ID: 19077522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degenerate intraductal papillary mucinous carcinoma with fish-mouth appearance of the papilla.
    Peixoto A; Moutinho-Ribeiro P; Macedo G
    J Gastrointestin Liver Dis; 2017 Jun; 26(2):113. PubMed ID: 28617877
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
    Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T
    J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasms of the pancreas: should we side step the side branches?
    Bishop MD; Wallace MB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):724-5. PubMed ID: 18602034
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
    Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M
    Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Neuroendocrine Tumors and Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review.
    Manuel-Vazquez A; Ramia JM; Latorre-Fragua R; Valle-Rubio A; Arteaga-Peralta V; Ramiro-Pérez C; de la Plaza-Llamas R
    Pancreas; 2018; 47(5):551-555. PubMed ID: 29683974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.
    Tanaka M; Fernández-Del Castillo C; Kamisawa T; Jang JY; Levy P; Ohtsuka T; Salvia R; Shimizu Y; Tada M; Wolfgang CL
    Pancreatology; 2017; 17(5):738-753. PubMed ID: 28735806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of intraductal papillary mucinous neoplasms of the pancreas.
    Allen PJ
    Surg Oncol Clin N Am; 2010 Apr; 19(2):297-310. PubMed ID: 20159516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with invasive carcinoma derived from IPMN who achieved long-term survival despite lymph node metastasis].
    Ueda N; Kaida D; Tomita Y; Ohnishi T; Funaki H; Fujita H; Kinami S; Nakano Y; Kosaka T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2202-4. PubMed ID: 25731470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overview of revised international consensus guidelines 2012 for the management of IPMN and MCN].
    Tamura K; Ohtsuka T; Tanaka M
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():400-4. PubMed ID: 25857056
    [No Abstract]   [Full Text] [Related]  

  • 19. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies.
    Adsay NV
    Surgery; 2003 May; 133(5):459-63. PubMed ID: 12773972
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathological features and long term outcome related to histopathological group.
    De Moor V; Arvanitakis M; Nagy N; Coppens E; Delhaye M; Closset J
    Hepatogastroenterology; 2012; 59(114):565-9. PubMed ID: 22353525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.